Andrea Ablasser wins the Leenaards Foundation's 2020 Science Prize Research EPFL EPFL Professor Andrea Ablasser shares the Prize with Professor Michel Gilliet from the CHUV. Their project aims to gain insight into the causes and effects of an overactive innate immune system in people with autoimmune diseases. Blocking sugar metabolism slows lung tumour growth Research EPFL Treatments that block two sugar-transporting proteins could help slow the growth of lung tumours, new research from EPFL suggests. The Antibody Engineer Research ETH Zurich For his doctoral thesis, Jonathan Kiefer manufactured antibodies that help the body’s own immune system to defend against leukaemia cells. With a Pioneer Fellowship from ETH Zurich, he now plans to make his dream a reality: further develop the molecules – and bring the therapy to market. First transparent surgical mask goes into production TechTransfer Empa Scientists of Empa and EPFL have developed a fully transparent surgical mask that will soon be produced on an industrial scale. The new startup HMCARE will market the masks and has already raised CHF 1 million to develop the manufacturing process. Microbiology offers relief for "colicky" babies Research ETH Zurich Vanesa Rocha Martin is studying how bacteria can be used to treat infant colic. As part of her Pioneer Fellowship, she is now turning her findings into a first-line therapy with a proven effect. The key lies in the genes Research ETH Zurich Whether or not patients will respond to a drug can be determined in advance. In this way, side effects can be avoided and patients benefit, writes Ernst Hafen. Previous 3 4 5 6 7 8 9 10... Next Page 6 of 13
